| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.885 | 78.195 | 89.758 | 104.604 | 105.780 | 82.566 | 96.995 | 120.259 | 135.772 | - |
| Total Income - EUR | 32.030 | 78.445 | 90.127 | 104.880 | 105.939 | 83.671 | 97.193 | 120.361 | 136.142 | - |
| Total Expenses - EUR | 13.493 | 29.867 | 18.366 | 25.008 | 32.625 | 32.131 | 24.598 | 65.510 | 23.209 | - |
| Gross Profit/Loss - EUR | 18.537 | 48.578 | 71.762 | 79.871 | 73.315 | 51.540 | 72.595 | 54.851 | 112.933 | - |
| Net Profit/Loss - EUR | 17.519 | 47.852 | 70.832 | 78.822 | 72.256 | 50.246 | 69.678 | 51.236 | 111.571 | - |
| Employees | 1 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | - |
Check the financial reports for the company - Phylgyn International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 988 | 595 | 209 | 33.043 | 25.278 | 17.809 | 10.579 | 3.756 | 0 | - |
| Current Assets | 19.026 | 50.159 | 72.872 | 57.062 | 54.767 | 36.799 | 60.126 | 61.987 | 108.510 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 177 | 50.300 | 94.187 | - |
| Cash | 19.026 | 50.159 | 72.872 | 57.062 | 54.767 | 36.799 | 59.949 | 11.688 | 14.324 | - |
| Shareholders Funds | 17.654 | 47.986 | 70.963 | 78.951 | 72.383 | 50.370 | 69.799 | 51.358 | 111.693 | - |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | - |
| Debts | 2.361 | 2.768 | 2.118 | 11.154 | 7.663 | 4.238 | 906 | 14.386 | 1.285 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Phylgyn International S.r.l.